drugset / Trial / NCT00980681

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)

NCT00980681

Phase 3 Terminated 13 enrolled Guerbet
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The study will evaluate the efficacy and safety of Dotarem enhanced MRA compared to TOF MRA in patients suffering from renal arterial disease.

Timeline

Start
2009-09
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadoterate meglumine Diagnostic / imaging agent 0.2 unknown

Indications